Acutus Medical, Inc. (AFIB)
2024-12-31 | ||||
---|---|---|---|---|
Revenue | 20,157 | |||
Cost of products sold | 19,144 | |||
Gross profit (loss) | 1,013 | |||
Selling, general and administrative | 10,436 | |||
Payments | 1,448 | |||
Gain on sale of business | 10,814 | |||
Total operating expenses | 1,070 | |||
Loss from operations | -57 | |||
Other revenue | 301 | |||
Interest income | 763 | |||
Interest expense | 5,758 | |||
Change in fair value of warrant liability | -215 | |||
Total other expense, net | -4,479 | |||
Loss from continuing operations before income taxes | -4,536 | |||
Income tax expense | - | |||
Net loss from continuing operations | -4,536 | |||
Loss from discontinued operations | -5,011 | |||
Net loss | -9,547 | |||
Foreign currency translation adjustment | 98 | |||
Comprehensive loss | -9,449 | |||
Basic eps | -0.32 | |||
Diluted eps | -0.32 | |||
Basic average shares | 29,768,208 | |||
Diluted average shares | 29,768,208 |